Nonhematopoietic cells represent a more rational target of invivo hedgehog signaling affecting normal or acute myeloid leukemia progenitors

Experimental Hematology

Volumn 41, Issue 10, 2013, Pages 858-869.e4

  Boyd, Allison L ^a,b   Salci, Kyle R ^a,b   Shapovalova, Zoya ^a   McIntyre, Brendan A S ^a   Bhatia, Mickie ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ERINACEIDAE; MURINAE;

EID: 84885863582     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.05.287     Document Type: Article

References (49)

1. Eppert K., Takenaka K., Lechman E.R., et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011, 17:1086.
2. Hope K.J., Jin L., Dick J.E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004, 5:738.
3. Sachlos E., Risueno R.M., Laronde S., et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 2012, 149:1284.
4. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730.
5. Lapidot T., Sirard C., Vormoor J., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645.
6. Campbell C., Risueño R.M., Salati S., Guezguez B., Bhatia M. Signal control of hematopoietic stem cell fate: Wnt, Notch, and Hedgehog as the usual suspects. Curr Opin Hematol 2008, 15:319.
7. Sengupta A., Banerjee D., Chandra S., et al. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 2007, 21:949-955.
8. Fiedler W., Vohwinkel G., Krauter J., et al. Expression of Gli2, a downstream mediator of the activated hedgehog pathway, represents a negative prognostic marker in AML. ASH Annual Meeting Abstracts 2011, 118:3535.
9. Irvine D.A., Copland M. Targeting hedgehog in hematological malignancy. Blood 2012, 119:2196-2204.
10. Jamieson C., Cortes J.E., Oehler V., et al. Phase 1 Dose-Escalation Study of PF-04449913, an oral hedgehog (hh) inhibitor, in patients with select hematologic malignancies. ASH Annual Meeting Abstracts 2011, 118:424.
11. Lin T.L., Matsui W. Hedgehog pathway as a drug target: smoothened inhibitors in development. OncoTargets Ther 2012, 5:47.
12. Gao J., Graves S., Koch U., et al. Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Stem Cell 2009, 4:548.
13. Hofmann I., Stover E.H., Cullen D.E., et al. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Stem Cell 2009, 4:559.
14. Mar B.G., Amakye D., Aifantis I., Buonamici S. The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis. Leukemia 2011, 25:1665.
15. Merchant A., Joseph G., Wang Q., Brennan S., Matsui W. Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood 2010, 115:2391.
16. Trowbridge J.J., Scott M.P., Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Nat Acad Sci U S A 2006, 103:14134.
17. Zhao C., Chen A., Jamieson C.H., et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009, 458:776.
18. Hooper J.E., Scott M.P. Communicating with hedgehogs. Nat Rev Mol Cell Biol 2005, 6:306.
19. Bhardwaj G., Murdoch B., Wu D., et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001, 2:172.
20. Fabian S.L., Penchev R.R., Jacques B.S., et al. Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol 2012, 180:1441-1453.
21. Omenetti A., Diehl A.M. The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol 2008, 294:G595-G598.
22. Shin K., Lee J., Guo N., et al. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 2011, 472:110.
23. O'Toole S.A., Swarbrick A., Sutherland R.L. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development. Expert Opin Ther Targets 2009, 13:1095-1103.
24. Tian H., Callahan C.A., DuPree K.J., et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Nat Acad Sci U S A 2009, 106:4254.
25. Yauch R.L., Gould S.E., Scales S.J., et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008, 455:406.
26. Dierks C., Beigi R., Guo G.-R., et al. Expansion of Bcr-Abl-Positive leukemic stem cells is dependent on hedgehog pathway activation. Cancer Cell 2008, 14:238.
27. Li L., Li M., Sun C., et al. Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk. Cancer Cell 2011, 20:591.
28. Bai L.-Y., Chiu C.-F., Lin C.-W., et al. Differential expression of Sonic hedgehog and Gli1 in hematological malignancies. Leukemia 2008, 22:226.
29. Kobune M., Takimoto R., Murase K., et al. Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells. Cancer Science 2009, 100:948.
30. Cheung A.M.S., Chow H.C.H., Liang R., Leung A.Y.H. A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia. Br J Haematol 2009, 144:484.
31. Majeti R., Becker M.W., Tian Q., et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Nat Acad Sci U S A 2009, 106:3396.
32. Gentles A.J., Plevritis S.K., Majeti R., Alizadeh A.A. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 2010, 304:2706.
33. Mills K.I., Kohlmann A., Williams P.M., et al. Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome. Blood 2009, 114:1063.
34. Sacchetti B., Funari A., Michienzi S., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 1:324.
35. Kubo H., Shimizu M., Taya Y., et al. Identification of mesenchymal stem cell (MSC)-transcription factors by microarray and knockdown analyses, and signature molecule-marked MSC in bone marrow by immunohistochemistry. Genes Cells 2009, 14:407.
36. Grundberg E., Brändström H., Lam K.C.L., et al. Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells. Physiol Genomics 2008, 33:301.
37. Mrugala D., Dossat N., Ringe J., et al. Gene expression profile of multipotent mesenchymal stromal cells: Identification of pathways common to TGFbeta3/BMP2-induced chondrogenesis. Cloning Stem Cells 2009, 11:61.
38. Wagner W., Bork S., Horn P., et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS ONE 2009, 4:e5846.
39. Rivron N.C., Raiss C.C., Liu J., et al. Sonic Hedgehog-activated engineered blood vessels enhance bone tissue formation. Proc Nat Acad Sci U S A 2012, 109:4413.
40. Guilloton F., Caron G., Ménard C., et al. Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. Blood 2012, 119:2556.
41. Ishikawa F., Yoshida S., Saito Y., et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007, 25:1315.
42. Oshima A., Kyle J.W., Miller R.D., et al. Cloning, sequencing, and expression of cDNA for human beta-glucuronidase. Proc Natl Acad Sci U S A 1987, 84:685.
43. Lee J.W., Chen Q., Knowles D.M., Cesarman E., Wang Y.L. β-Glucuronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia. J of Mol Diagnostics 2006, 8:385.
44. Wang Y.L., Lee J.W., Cesarman E., Jin D.K., Csernus B. Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts. J Mol Diagnostics 2006, 8:231.
45. Shultz L.D., Schweitzer P.A., Christianson S.W., et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. JImmunol 1995, 154:180.
46. Vermeulen L., De Sousa E., Melo F., et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010, 12:468.
47. Incardona J.P., Gruenberg J., Roelink H. Sonic hedgehog induces the segregation of patched and smoothened in endosomes. Curr Biol 2002, 12:983.
48. Siggins S.L., Nguyen N.Y., McCormack M.P., et al. The hedgehog receptor Patched1 regulates myeloid and lymphoid progenitors by distinct cell-extrinsic mechanisms. Blood 2009, 114:995.
49. Liesner R.J., Goldstone A.H. ABC of clinical haematology. The acute leukaemias. BMJ 1997, 314:733-736.